期刊文献+

半乳凝素-3在侵袭性垂体泌乳素腺瘤中表达 被引量:8

Expression of Galectin-3 in Invasive Prolactinomas
下载PDF
导出
摘要 目的观察半乳凝素-3(Gal-3)在垂体泌乳素腺瘤中的表达情况。方法采用免疫组织化学方法,测定16例侵袭性垂体泌乳素腺瘤和16例非侵袭性垂体泌乳素腺瘤中Gal-3的表达水平。结果在侵袭性垂体泌乳素腺瘤和非侵袭性垂体泌乳素腺瘤中均有Gal-3的表达,其中侵袭性垂体泌乳素腺瘤中Gal-3的表达水平明显高于非侵袭性垂体泌乳素腺瘤(P<0.05雪。结论Gal-3增高可能与垂体泌乳素腺瘤的侵袭性有关。 Objective To investigate the expression of galectin-3(Gal-3)in prolactinomas. Methods Expressions of Gal-3 were evaluated by immunohistochemistry using polyclonal antibody in 16 invasive prolactinomas and 16 prolactinomas. Results Gal-3 was expressed both in invasive prolactinomas and noninvasive prolactinomas while significantly higher expression seen in the invasive prolactinomas(P < 0.05). Conclusion Gal-3 expression may be used as a useful indicator to determine the invasiveness and prognosis of prolactinomas.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2005年第3期380-381,共2页 Acta Academiae Medicinae Sinicae
关键词 侵袭性垂体泌乳素腺瘤 半乳凝素-3 免疫组织化学 invasive prolactinomas galectin-3 immunohistochemistry
  • 相关文献

参考文献7

  • 1Burger PC, Scheithauer BW, Vogel FS. Surgical pathology of the nervous system and its coverings, New York:CHURCHILL LIVINGSTONE 2002.441-490
  • 2Partridge EA, Le Roy C, Di Guglielmo GM, et ol.Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science, 2004, 306:120-124
  • 3Niedziela M, Maceluch J, Korman E. Galectin-3 is not an universal marker of malignancy in thyroid nodular disease in children and adolescents. J Clin Endocrinol Metab, 2002,87:4411-4415
  • 4Scheithauer BW, Kovacs KT, Laws ER, et al. Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg, 1986, 65:733-744
  • 5Yoshii T, Fukumori T, Honjo Y, et al. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. J Biol Chem, 2002, 277:6852-6857
  • 6Mehrotra P, Okpokam A, Bouhaidar R, et al. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms. Histopathology, 2004, 45:493-500
  • 7Riss D, Jin L, Qian X, et al. Differential expression of Galectin-3 in pituitary tumors. Cancer Res, 2003, 63:2251-2255

同被引文献108

  • 1王明栋,王洪,史彦芳,马文斌,王任直.p27与垂体增生[J].国外医学(神经病学.神经外科学分册),2004,31(5):445-447. 被引量:1
  • 2苏长保,任祖渊,王任直,许志勤,陶蔚,杨义,马文斌,李永宁,连伟,幸兵,杨众.大型和巨大型垂体腺瘤经蝶显微外科治疗的疗效及处理策略[J].中华神经外科杂志,2005,21(3):138-141. 被引量:64
  • 3魏少波,周定标,姜金利,孟祥辉,佟怀宇.经蝶切除垂体腺瘤手术后残留原因分析及再治疗[J].中华神经外科杂志,2005,21(3):153-155. 被引量:8
  • 4惠国桢,王清,李向东,徐峰,高恒,吴思荣,俞文华,吴智远.经蝶窦显微手术治疗男性泌乳素腺瘤的长期随访分析[J].中华神经外科杂志,2005,21(9):535-538. 被引量:3
  • 5[1]RUEB EL K H,JIN L,QIAN X.et al.Effects of DNA methylation on galectin-3 expression in pituitary tumors[J].Cancer Res,2005,65(4):1136-1140.
  • 6[3]GAFFEY T A JR,SCHEITHAUER B W,LEECH R W,et al.pituitary adenoma:a DNA flow cytometrie study of 192 clinicalopathologically characterized tumors[J].Clin Neuropathol,2005,24(2):56-63.
  • 7[5]ZHAO D,TOMONO Y,NOSE T.Expression ofp27kipl and ki-67 in pituitary adenoma:an investigation of marker of adenoma invasiveness[J].Acta Neurochir,1999,141(2):187-192.
  • 8[6]OLIVEIRA M,MARRONI C P,PIZARRO C B,et al.Expression of p53 protein in pituitary adenomas[J].Braz J Med Biol Res,2002,35(5):561-565.
  • 9[7]YOSHINO A,KATAYAMA Y,FUKUSHIMA T,et al.Telomerase activity in pituitary adenoma:significance of telomerase expression in predicting pituitary adenoma recurrence[J].J Neurooncol,2003,63(2):155-162.
  • 10[8]KONTOGEORGOS G.Innovations and controversies in the WHO classification of pituitary adenomas[J].Aeta Neuropathol (Berl),2006,111(1):73-75.

引证文献8

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部